CTRI/2024/01/061061Not yet recruitingUnknown
A Prospective, open-label Post-marketing clinical Follow-up study aims to assess the safety, performance, and user acceptance of the 72 Hours TraxIt® Cholesteric Liquid Crystal (CLC) Skin Patch Thermometer in a real-world clinical setting - NA
Medical Indicators Inc0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. Subjects will be recruited from both in-patient and out-patient settings of mixed population, adults, pediatric and elderly individuals.
- •i. Adults aged 18 to 65 years
- •ii. Pediatric patients
- •Infants – 6 month to 1 aged Toddlers- 1 to 3 years
- •Children- 3 years to 12 years
- •iii. Adolescents- 12 years to 18 years
- •iv. Elderly individual aged 65 years and above
- •2. Able to provide inform consent form and for pediatric patients from legal guardian.
- •3. Inpatients admitted to the hospital for various medical conditions requiring continuous temperature monitoring.
- •4. Outpatient with chronic conditions or specific health conditions that necessitate continuous temperature monitoring
Exclusion Criteria
- •1. Children with skin condition or wounds in the patch application area.
- •2. Children with cognitive impairments affecting their ability to wear patch or follow instruction.
- •3. Individual with known allergies to adhesives or skin sensitivities in the patch application area.
Investigators
Similar Trials
Not yet recruiting
Phase 4
Efficacy of Micon Gold Capsule in DiabetesCTRI/2023/02/049894Med Pharma CRO
Not yet recruiting
Phase 4
Efficacy of Vatantak Gold Tablet and Pain Kill Oil in painful inflammatory Musculoskeletal ConditionsCTRI/2022/11/047342Med Pharma CRO
Not yet recruiting
Phase 4
To evaluate clinical outcomes and patient satisfaction with Trifocal Intraocular lensCTRI/2024/01/061967Tirupati Eye Centre and research Institute
Completed
Phase 4
Efficacy of Yuvnam Shaurya Oil on reducing Erectile DysfunctioCTRI/2022/09/045961YUVNAM PRIVATE LIMITED57
Not yet recruiting
Not Applicable
Clinical study to evaluate the Efficacy of Nattokinase as a Nutraceutical supplement for preventing blood clot in Type II Diabetes Mellitus Patients.CTRI/2019/10/021808Dr Debananda Sahoo